JP2010526776A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526776A5
JP2010526776A5 JP2010506268A JP2010506268A JP2010526776A5 JP 2010526776 A5 JP2010526776 A5 JP 2010526776A5 JP 2010506268 A JP2010506268 A JP 2010506268A JP 2010506268 A JP2010506268 A JP 2010506268A JP 2010526776 A5 JP2010526776 A5 JP 2010526776A5
Authority
JP
Japan
Prior art keywords
seq
peptide
sequence
composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506268A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526776A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/005316 external-priority patent/WO2008133961A2/en
Publication of JP2010526776A publication Critical patent/JP2010526776A/ja
Publication of JP2010526776A5 publication Critical patent/JP2010526776A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506268A 2007-04-24 2008-04-23 Igf−1r結合タンパク質およびアンタゴニスト Withdrawn JP2010526776A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92598207P 2007-04-24 2007-04-24
PCT/US2008/005316 WO2008133961A2 (en) 2007-04-24 2008-04-23 Igf-1r binding proteins and antagonists

Publications (2)

Publication Number Publication Date
JP2010526776A JP2010526776A (ja) 2010-08-05
JP2010526776A5 true JP2010526776A5 (enExample) 2011-06-16

Family

ID=39731759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506268A Withdrawn JP2010526776A (ja) 2007-04-24 2008-04-23 Igf−1r結合タンパク質およびアンタゴニスト

Country Status (7)

Country Link
US (1) US20110039779A1 (enExample)
EP (1) EP2152742B1 (enExample)
JP (1) JP2010526776A (enExample)
CN (1) CN101802001A (enExample)
AU (1) AU2008244496A1 (enExample)
CA (1) CA2685115A1 (enExample)
WO (1) WO2008133961A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4460514A2 (en) * 2022-01-03 2024-11-13 Nighthawk Biosciences, Inc. Cellular uptake peptide-therapeutic payload compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173005B2 (en) * 1998-09-02 2007-02-06 Antyra Inc. Insulin and IGF-1 receptor agonists and antagonists
US6875741B2 (en) 1998-09-02 2005-04-05 Renuka Pillutla Insulin and IGF-1 receptor agonists and antagonists
JP2004512010A (ja) 2000-03-29 2004-04-22 ディージーアイ・バイオテクノロジーズ・エル・エル・シー インスリン及びigf−1受容体のアゴニスト及びアンタゴニスト

Similar Documents

Publication Publication Date Title
TW201018471A (en) Multiple exon skipping compositions for DMD
JP2014518612A5 (enExample)
JP7049262B2 (ja) 結合組織成長因子を標的とするrna複合体を用いた特発性肺胞線維症の治療
AU2019317789B2 (en) Cell-penetrating peptides
JP2018512454A5 (enExample)
JP2010518079A5 (enExample)
WO2008022046B1 (en) Dicer substrate rna peptide conjugates and methods for rna therapeutics
JP2010538005A5 (enExample)
JP2013509389A5 (enExample)
JP7674031B2 (ja) 細胞透過性ペプチド
JP2015522264A5 (enExample)
JPWO2019156137A5 (enExample)
JP2013503110A5 (enExample)
JP2013523718A5 (enExample)
JP2013504603A5 (enExample)
CA2744339A1 (en) Method for treating parkinson's disease
JP2010526776A5 (enExample)
JP7750839B2 (ja) ピロールイミダゾールポリアミド、TGFβ遺伝子発現抑制剤、医薬組成物
US20220380774A1 (en) Asymmetric sirna inhibiting expression of pd-1
JP2015533372A5 (enExample)
WO2019227004A1 (en) Organic compounds
JP2024518125A (ja) 組織再生の促進に有用なhmgb1関連ポリペプチド、それを含む組成物及びその使用
JP7412576B2 (ja) 腎がんの相乗的治療におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の適用
JP2009526861A5 (enExample)
CN101802001A (zh) Igf-1r结合性蛋白和拮抗剂